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Summary
A longstanding hypothesis is that ion channels are
present in the membranes of synaptic vesicles and
might affect neurotransmitter release. Here we demon-
strate that TRPM7, a member of the transient receptor
potential (TRP) ion channel family, resides in the mem-
brane of synaptic vesicles of sympathetic neurons,
forms molecular complexes with the synaptic vesicle
proteins synapsin I and synaptotagmin I, and directly
interacts with synaptic vesicular snapin. In sympa-
thetic neurons, changes in TRPM7 levels and channel
activity alter acetylcholine release, as measured by
EPSP amplitudes and decay times in postsynaptic
neurons. TRPM7 affects EPSP quantal size, an intrin-
sic property of synaptic vesicle release. Targeted pep-
tide interference of TRPM7’s interaction with snapin
affects the amplitudes and kinetics of postsynaptic
EPSPs. Thus, vesicular TRPM7 channel activity is
critical to neurotransmitter release in sympathetic
neurons.
Introduction
Nonselective cationic channels of the TRP ion channel
family participate in the sensation of pain, heat, and
taste, and in neuronal plasticity (Clapham, 2003; Ram-
sey et al., 2006). Although the function of many TRP
channels is still elusive, it is assumed that their main
role is acting as divalent ion conductors through the
plasma membrane. Ion channel proteins are commonly
observed in both the plasma membrane and on intracel-
lular organelles, but justifiably their localization on inter-
nal membranes is usually assumed to be as cargo in
transit to the plasma membrane. Notable exceptions
are the well-established endoplasmic reticular Ca2+-
release channels (IP3 and ryanodine receptors), several
ClC chloride channels required for acidification of syn-
aptic vesicles (Jentsch et al., 2005), and the only known
yeast TRP channel (Palmer et al., 2001). Mucolipins
*Correspondence: dclapham@enders.tch.harvard.edu(TRPML channels) are presumed intracellular vesicular
channels (Di Palma et al., 2002; LaPlante et al., 2002),
but their function in vesicles is not well understood.
Neurotransmitter vesicles release their cargoes by
fusion with the plasma membrane followed by diffusion
of their contents into the intercellular space. The fusion
process itself is not completely understood, but involves
a complex of proteins with specialized functions that al-
low them to achieve close approximation of the vesicle
to the plasma membrane and sense changes in [Ca2+]
that trigger rapid fusion (Sudhof, 2004). Although neuro-
transmitter release requires ion channels, ion channels
are best known for their function as the plasma mem-
brane mediators of the timing and entry of Ca2+ into
the cell, which in turn triggers vesicle fusion. Functional
ion channels have been recorded in preparations of syn-
aptic vesicles (Yakir and Rahamimoff, 1995; Kelly and
Woodbury, 1996), and a few well-established plasma
membrane channels have been proposed to localize to
vesicles and regulate their ionic equilibrium (Ehrenstein
et al., 1991; Grahammer et al., 2001), but their molecular
identities and role in neurotransmitter release has not
yet been established. The ClC-3 chloride channel is
present in synaptic vesicles, but mice in which this
gene had been deleted did not exhibit abnormalities in
synaptic transmission in hippocampal slices (Stobrawa
et al., 2001).
In summary, there are unsolved major questions
about the presence and function of ion channels in ves-
icles. What is the complement of ion channels in the
neurotransmitter vesicle, and are these channels impor-
tant for neurotransmitter release? During studies of the
TRPM7 protein, we noticed that it was present in synap-
tic vesicles and bound to several proteins of the synap-
tic vesicle fusion apparatus. TRPM7 is an ion channel
that is permeant to monovalent cations, Ca2+, and Mg2+,
and it is required for cell viability, but little is known
about its biological function (Clapham, 2003; Ramsey
et al., 2006). Here we demonstrate TRPM7’s localization
to synaptic vesicles of sympathetic neurons and explore
its role in synaptic transmission.
Results
TRPM7 Is Localized to Synaptic Vesicle Membranes
in Sympathetic Neurons
In an attempt to understand the function of TRPM7, we
set out to identify proteins that interact with TRPM7
using yeast two-hybrid screening. Evolutionarily con-
served protein fragments of the human TRPM7 N- and
C-terminal cytoplasmic domains were chosen as baits.
Screening of a human brain library with bait containing a
portion of the TRPM7 N terminus (amino acids 87–326 of
Q96QT4) bound full-length snapin protein (O95295) as a
potential TRPM7 interactor. Snapin is a ubiquitously
expressed, 15 kDa protein implicated in vesicle fusion
(Buxton et al., 2003). The protein is reportedly highly
enriched in purified synaptic vesicles (Ilardi et al., 1999)
and affects the binding of synaptotagmin to SNAREs,
and when phosphorylated by protein kinase A, it
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et al., 2001; Thakur et al., 2004).
Our finding of the interaction of snapin with TRPM7,
and snapin’s putative role in neurotransmitter release,
motivated us to test whether TRPM7 functions in syn-
aptic transmission. To determine whether TRPM7 was
expressed in a synaptic compartment, we measured
TRPM7 content in purified rat brain synaptosomes and
synaptic vesicles by western blotting. Figure 1A shows
that TRPM7 is enriched in a synaptic vesicle preparation
compared with crude brain microsomes and purified
synaptosomes, and is absent in postsynaptic densities.
This finding suggests that TRPM7 is situated in the
membrane of synaptic vesicles. To confirm that TRPM7
resides in synaptic vesicles, we immunoprecipitated
TRPM7 from a purified synaptic vesicle preparation
and probed these precipitates for synaptic vesicle-
specific proteins. The synaptic vesicle preparation was
essentially free of plasma membrane and nonvesicular
components of SNARE as demonstrated by the absence
of Na, K-ATPase, a plasma membrane marker (Fig-
ure 1A), and SNAP25 and syntaxin (see Figure S1 in the
Supplemental Data). Both synaptotagmin I and synapsin
I are primarily localized in neuronal synaptic vesicles
(Sudhof, 2002; Greengard et al., 1994). Figure 1B shows
that TRPM7 coimmunoprecipitated the synaptic vesicle
proteins synaptotagmin I and synapsin I. Reverse immu-
noprecipitation with synaptotagmin I and synapsin I an-
tibodies also showed specific coimmunoprecipitation of
TRPM7 with these proteins (Figure 1B). VAMP2, another
synaptic vesicle-specific protein, was not bound to
TRPM7 immunoprecipitated from brain (Figure 1B), and
this protein served as an additional negative control for
the specificity of TRPM7’s interaction with synaptotag-
min I and synapsin I.
The experiments so far supported TRPM7’s localiza-
tion to synaptic vesicles, but did not address the type
of neuron expressing TRPM7 in their synaptic vesicles.
Confocal immunofluorescence techniques were used to
examine the distribution of TRPM7 in neurons. TRPM7
was not observed in synapses of mature hippocampal
neurons (2 to 3 weeks in vitro; data not shown). How-
ever, TRPM7 was highly expressed and colocalized with
the presynaptic marker synaptophysin in the neuromus-
cular junction (Figure 1C), suggesting that TRPM7 is
present in the terminals of motor neurons. We reasoned
that TRPM7 might be confined to synapses of neurons
secreting positively charged neurotransmitters, such as
acetylcholine, rather than synapses of neurons secret-
ing the negatively charged glutamate and GABA neuro-
transmitters. Indeed, we found TRPM7 labeling (by two
distinct antibodies) in varicosities of the processes of
superior cervical ganglion (SCG) sympathetic neurons
(Figure 1D), onion-shaped structures that are packed
with synaptic vesicles (Bennett, 1972; Buckley and
Landis, 1983; Jackson and Cunnane, 2001). TRPM7-ex-
pressing, cultured SCG neurons were immunogold-la-
beled with TRPM7 antibody, and clearly show TRPM7
inside the onion-shaped varicosity (Figure 2A). A magni-
fied view suggests that TRPM7 is restricted to the mem-
brane of the synaptic vesicles in these varicosities
(Figure 2B). This labeling was specific since antibody
preabsorption with antigen blocked vesicular labeling,
and mitochondria adjacent to these synaptic vesicleswere not labeled (Figures 2B and 2C). Most significantly,
TRPM7 was not detected in the plasma membrane of
the varicosities.
Alteration of TRPM7 Levels in Presynapses
Affects Neurotransmission
So far, the data indicate that TRPM7 is located in
the membrane of synaptic vesicles and interacts with
Figure 1. TRPM7 Is a Synaptic Vesicle Protein Localized in the Neu-
romuscular Junction and Presynapses of Sympathetic Neurons
(A) TRPM7 is enriched in a rat brain synaptic vesicle preparation. Ten
micrograms of protein from brain microsomes (P2), synaptosomes
(Syn), synaptic vesicles (SV), and postsynaptic densities (PSD)
were probed on a western blot with TRPM7-CFP antibody. Synapto-
physin was probed in the same samples as a marker of synaptic ves-
icles; a lysate of HEK 293T cells overexpressing TRPM7 (labeled M7)
was used as a marker.
(B) Synaptic proteins synaptotagmin 1 (Syt1) and synapsin 1 (Syn1)
coimmunoprecipitate with TRPM7. Solubilized rat brain synaptic
vesicle preparations were immunoprecipitated (IP) with TRPM7-
CFP antibody and probed on western blot with TRPM7-C47, Syt1,
Syn1, and VAMP2 antibodies. The same preparation was immuno-
precipitated with Syt1 and Syn1 antibodies and probed on western
blot as indicated. Immunoprecipitation with normal rabbit immuno-
globulins (IgG) is shown as a negative control. The same result
was obtained when TRPM7 was immunoprecipitated with TRPM7-
C47 antibody (not shown). X (% of sample used for IP and shown
as input) = 2% for TRPM7, 1.5% for Syt1, 0.5% for Syn1, and 1.5%
for VAMP2.
(C) TRPM7 is colocalized with the presynaptic marker, synaptophy-
sin, in the neuromuscular junction. Confocal images of 5 m sections
of mouse gastrocnemius muscle demonstrate labeling with
TRPM7-CFP antibody and anti-synaptophysin. DIC, differential inter-
ference contrast image.
(D) TRPM7 colocalizes with synaptophysin in synaptic varicosities of
mature rat superior cervical ganglion (SCG) sympathetic neurons.
Confocal images of sympathetic neurons 40 days in vitro were la-
beled with TRPM7-CFP antibody and anti-synaptophysin. TRPM7-
C47 antibody labeling showed the same pattern and colocalization
withsynaptophysin (datanotshown).TRPM7antibodypreabsorption
with antigenic peptides suppressed the labeling (data not shown).
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487Figure 2. TRPM7 Is Expressed in the Mem-
branes of Synaptic Vesicles of Cultured
SCG Neurons
(A and B) Immunogold electron micrographs
showing labeling of synaptic vesicles in neu-
ronal process varicosities with TRPM7-CFP
antibody. m, mitochondria; PM, plasma
membrane. Insert displays magnified boxed
area in (B).
(C) Statistical summary of the density of im-
munogold labeling of synaptic vesicles (6 an-
tigenic peptide block) and mitochondria
(serving as a negative control). Data is from
three independent labeled samples.proteins that are known to be involved in synaptic vesi-
cle exocytosis and neurotransmitter release—synapsin I
(Chi et al., 2001), synaptotagmin I (Chapman, 2002), and
snapin (Ilardi et al., 1999; Chheda et al., 2001). We hy-
pothesized that the TRPM7 protein situated in the mem-
brane of synaptic vesicles is involved in the regulation
of neurotransmitter release. Amperometric detection of
evoked catecholamine release with carbon fiber elec-
trodes (Robinson et al., 1995) has been useful in sympa-
thetic neurons (Zhou and Misler, 1995). However, in ini-
tial experiments with pheochromocytoma (PC12) cells,
we found that TRPM7 specifically localized to small
synaptic-like vesicles containing acetylcholine and was
not expressed in dense core vesicles secreting cate-
cholamines (data not shown). Since amperometry
does not detect acetylcholine release, and since there
is no evidence to suggest that these vesicles also
contain catecholamines, we chose to measure excit-
atory postsynaptic potentials (EPSPs) from synaptically
coupled neurons as an assay of synaptic vesicular
release. To test the function of TRPM7 in synaptic vesi-
cle release, we altered TRPM7 protein levels or channel
activity in presynaptic neurons and measured EPSP
amplitudes and kinetics in unaltered postsynaptic
neurons.
Sympathetic neurons isolated from rat SCG were cho-
sen as an experimental model since (1) TRPM7 is ex-
pressed in synaptic vesicles of SCG neurons in culture;
(2) proteins are efficiently ectopically expressed in these
neurons after DNA microinjection (Mochida et al., 2003);
and (3) most adjacent neurons are connected by synap-
ses, and recordings from neurons neighboring the stim-
ulated neuron reproducibly yield cholinergic EPSPs
(Mochida et al., 1994). First, we increased TRPM7 by
overexpressing GFP-TRPM7; heterologous expression
of GFP-TRPM7 in HEK 293T cells confirmed that the
channel properties of this construct were indistinguish-able of those for wild-type TRPM7 (data not shown).
Second, TRPM7 synthetic siRNAs to rat TRPM7 (see
Experimental Procedures) were employed to decrease
levels of functional TRPM7 protein. In several model
systems, TRPM7 siRNAs effectively knocked down
TRPM7 protein levels. siRNAs cotransfected with rat
TRPM7 into HEK 293T cells abrogated TRPM7 protein
expression (Figure S2A). More than 90% of endogenous
TRPM7 protein expression was suppressed in TRPM7-
siRNA-transfected rat PC12 cells (Figure S2B). Finally,
injected TRPM7-siRNA1 knocked down 40%, and
TRPM7-siRNA2 nearly 90%, of endogenous TRPM7
protein in cultured rat SCG neurons used for electro-
physiological recordings (Figure S2C).
Neurons were injected with GFP-TRPM7 cDNA or
siRNA along with a GFP-expressing vector in order to
visualize presynaptic neurons and assure that altered
TRPM7 was presynaptically localized (Figure 3A). Action
potentials were generated every 200 ms in presynaptic
(GFP-labeled) neurons and EPSPs were recorded in
adjacent synaptically coupled nontransfected neurons
(modified Krebs’ solution containing 0.2 mM Ca2+and
5 mM Mg2+ was used in order to record release events
of a few synaptic vesicles; Figure 3B).
The average EPSP amplitude recorded from postsyn-
aptic neurons of TRPM7-overexpressing presynaptic
neurons was 1.3-fold larger than in nontransfected syn-
apses (2.26 6 0.08 mV compared to 1.79 6 0.06 mV).
The average EPSP amplitudes were decreased to 64%
of control levels by siRNA1 knockdown of TRPM7
(1.15 6 0.05 mV, Figure 3C). Modulation of presynaptic
TRPM7 resulted in prominent changes in postsynaptic
EPSP amplitude histograms. TRPM7 overexpression
increased the proportion of larger-amplitude EPSPs
compared with controls, while siRNA1-induced TRPM7
knockdown increased the proportion of small-ampli-
tude EPSPs (Figure 3F). Analysis of cumulative
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488Figure 3. Presynaptic TRPM7 Levels Affect Synaptic Transmission between SCG Neurons in Culture
(A) Fluorescent image of SCG neurons transfected with GFP-TRPM7 (green) and a nontransfected neuron (outlined in white). Pre, presynaptic
neuron; Post, postsynaptic neuron. Scale bar, 25 mm.
(B) Representative EPSPs recorded postsynaptically (Post EPSPs) in a modified Krebs’ solution containing 0.2 mM Ca2+ and 5 mM Mg2+. Pre-
synaptic neurons were stimulated at 5 Hz to generate ten action potentials (Pre APs). The three sets of four traces are examples of postsynaptic
responses from presynaptic neurons transfected by GFP only (GFP), GFP-TRPM7, and TRPM7 siRNA1, respectively.
(C) Mean amplitude of EPSPs in a modified Krebs’ solution containing 0.2 mM Ca2+ and 5 mM Mg2+. Fifty to one hundred and ten action potentials
were generated in each synaptic pair of presynaptic neurons transfected with the construct indicated. Data recorded from nine to ten synapses
(Non-transfected, 9; Control GFP, 9; GFP-TRPM7, 10; Control siRNA, 9; TRPM7 siRNA1, 10) are averaged for each bar (*p < 0.05, Student’s un-
paired t test). In total, 910 action potentials were evoked in presynaptic neurons transfected with each construct. In experiments with TRPM7
siRNA2-injected neurons, 20 action potentials were generated in each of 23 neuronal pairs and no EPSP was recorded.
(D) Mean quantal size (q) calculated by the variance of the amplitude of EPSP recordings as described in (C). Data for each construct were
averaged (*p < 0.05, Student’s unpaired t test).
(E) Mean decay time of EPSPs. Data measured by EPSP recordings as described in (C) were averaged for each bar (*p < 0.05, Student’s unpaired
t test).
(F) Amplitude histograms of EPSPs, evoked by 910 action potentials in presynaptic neurons transfected with the constructs indicated as de-
scribed in (C) (Non-transfected, n = 224; GFP-TRPM7, n = 215; Control GFP, n = 253; TRPM7 siRNA, n = 134; and Control siRNA, n = 290).
(G) Cumulative amplitude histograms for EPSP recordings shown in (F). Control GFP-transfected (green) versus GFP-TRPM7 (red) or control
siRNA (light blue) versus TRPM7 siRNA (dark blue). Histograms were significantly different at p < 0.00001 based on the Kolmogorov-Smirnoff
test.
In all figures, data values represent mean 6 SEM.histograms showed that these differences were statisti-
cally significant (Figure 3G). To examine these effects in
more detail, we carried out quantal analysis of EPSPs.
According to the quantal release hypothesis, the effi-
cacy of a synaptic connection depends on the size of
the postsynaptic response to a quantum of the transmit-
ter and the number of quanta released per action poten-
tial. Analysis showed that alteration of TRPM7 expres-
sion level mainly affected quantal size (Figure 3D), not
quantal content (data not shown). This finding suggests
that TRPM7 affects intrinsic properties of synaptic ves-
icle release, such as the amount of the releasable neuro-transmitter (Rahamimoff and Fernandez, 1997) or the
dynamics of the fusion pore (Burgoyne and Barclay,
2002; Pawlu et al., 2004).
EPSP kinetics were also affected by changes in
TRPM7 protein expression. EPSP decay times were in-
creased by presynaptic TRPM7 overexpression but de-
creased by presynaptic TRPM7 knockdown (Figure 3E).
In nontransfected synapses, the mean decay time from
peak to 2/3 of peak amplitude was 3.26 0.2 ms. Presyn-
aptic TRPM7 overexpression increased mean decay
time by 1.3-fold to 4.1 6 0.4 ms, while TRPM7 siRNA1
knockdown decreased decay times to 78% of control
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489Figure 4. Dominant-Negative TRPM7 Mutant
Abrogates Synaptic Transmission between
SCG Neurons
(A) Wild-type GFP-TRPM7 (TRPM7wt) was
coexpressed with a 5-fold excess of unla-
beled TRPC1 or the pore mutant of TRPM7
(TRPM7mut). Expression of TRPC1 and
TRPM7mut (both FLAG-tagged) in green
(GFP) cells was confirmed by immunofluores-
cence. TRPM7mut abrogated TRPM7 cur-
rent, acting as a dominant-negative subunit
(TRPM7-DN). Each bar graph is the average
current measured at +100 mV from six to
eight cells.
(B) Expression of TRPM7-DN in cultured sym-
pathetic neurons suppresses EPSPs. 1500 (63
250 pulses at 5 Hz) action potentials were
generated in each synaptic pair of presynap-
tic neurons transfected with the construct
indicated, and averages of 151 (nontrans-
fected), 131 (control GFP), 73 (TRPM7-DN in
0.5 mM) and 250 (nontransfected in 0.5 mM
Ca2+) EPSPs were recorded in response to
250 action potentials. Data recorded from
four to eight synapses were averaged. For
the bar graph of TRPM7-DN in 0.2 mM Ca2+,
20 action potentials were generated in five
neuronal pairs and no EPSP was recorded.levels (2.5 6 0.2 ms). These data suggest that the kinet-
ics of acetylcholine release from synaptic vesicles were
altered by changes in TRPM7 levels in presynaptic ter-
minals.
EPSP amplitudes, and especially the time courses of
EPSPs, are affected by changes in the membrane prop-
erties of postsynaptic cells. It was important to test for
such changes when TRPM7 levels were modulated in
adjacent presynaptic neurons. Thus, we measured the
resting potential, membrane resistance, membrane ca-
pacitance, and ACh responses in the postsynaptic neu-
rons surrounding neurons injected with GFP-TRPM7
DNA or siRNA. No significant changes to postsynaptic
neuron membrane properties or ACh receptor activa-
tion were observed under these conditions (Figure S3).
Thus, the changes observed in the EPSP amplitude,
quantal size, and decay times were associated with
neurotransmitter release, since presynaptic, but not
postsynaptic, TRPM7 levels were altered by cDNA or
siRNA transfection.
In additional experiments, another TRPM7 siRNA
(siRNA2) was transfected in the SCG neurons 5 days
prior to recordings. This second siRNA was much more
efficient than siRNA1, decreasing TRPM7 protein by
>90% (Figure S2C). siRNA2 expression resulted in com-
plete suppression of postsynaptic responses (0.2 mM
Ca2+; Figure 3C, n = 23 neurons). To verify that postsyn-
aptic neurons coupled to the siRNA2-injected neurons
were functionally active, the external [Ca2+] was in-
creased to 1 mM, whereupon small amplitude EPSPs
from siRNA2-expressing synapses were observed
(1.30 6 0.13 mV, n = 8 pairs, data not shown). These
EPSPs could not be compared to postsynaptic re-
sponses from control neurons under the same condi-
tions, since at 1 mM [Ca2+]o, all postsynaptic neurons
generated action potentials in response to repetitive
presynaptic stimulation (control siRNA-transfected neu-
rons; four pairs). These results confirm that TRPM7 iscritical for SCG neurotransmitter release at physiologi-
cal levels of external [Ca2+].
TRPM7 Dominant-Negative Pore Mutation
Suppresses Synaptic Transmission
Is ion conduction via the TRPM7 pore, not just the pro-
tein itself, relevant to TRPM7-dependent neurotransmit-
ter release? To answer this question, pore residues of
TRPM7 were mutated and the resulting mutants tested
in heterologous expression. Mutation of highly con-
served amino acids located in the 6th putative trans-
membrane domain (amino acids 1090–1092, NLL mu-
tated to FAP; NP_067425) resulted in almost complete
suppression of TRPM7 current (Figure 4A). Control ex-
periments demonstrated that the mutation did not affect
TRPM7 protein expression levels (not shown). Coex-
pression of the wild-type TRPM7 with mutant TRPM7
suppressed the WT channel (Figure 4A), while coexpres-
sion with a TRPC1 splice variant (which did not yield cur-
rent by itself) did not affect TRPM7 current (Figure 4A).
We conclude that the TRPM7 NLL>FAP mutation acts
as a dominant-negative subunit that assembles with
TRPM7 and forms a nonconducting channel protein.
Expression of the dominant-negative TRPM7
(TRPM7-DN) mutant in SCG neurons resulted in com-
plete suppression of postsynaptic responses from
transfected neurons (0.2 mM Ca2+; Figure 4B). To verify
that these postsynaptic neurons were functionally ac-
tive, [Ca2+]o was increased to 0.5 mM. Under these con-
ditions, low amplitude EPSPs with an acceptable signal/
noise ratio for data analysis could be recorded from
TRPM7-DN-expressing synapses. Mean EPSP ampli-
tude from these synapses was 21% of EPSP amplitude
from nontransfected controls (Figure 4B). This suppres-
sion of synaptic transmission by dominant-negative
TRPM7 subunits strongly suggests that TRPM7’s ionic
conductance is critical for neurotransmitter release.
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490Figure 5. Native Snapin Binds Synapsin I,
Synaptophysin I, and TRPM7
(A) Coimmunoprecipitation of synaptotagmin
I (SytI) and synapsin I (SynI) with snapin from
rat brain synaptic vesicles. Triton X-100 solu-
bilized synaptic vesicle proteins were immu-
noprecipitated (IP) with anti-snapin antise-
rum, Syt1 and Syn1 antibody, or normal
rabbit serum (NS) and probed on western
blot with the antibody indicated. The data
suggest that snapin is in a molecular complex
with the synaptic vesicle-specific proteins
synaptotagmin I and synapsin I. In these ex-
periments, snapin did not coimmunoprecipi-
tate synaptic vesicle-specific VAMP2 protein,
serving as a negative control. X (% of sample
used for IP and shown as input) = 4% for sna-
pin, 0.6% for Syt1, 0.2% for Syn1, and 0.6%
for VAMP2.
(B) TRPM7 and snapin cross-immunoprecip-
itate each other from purified synaptic vesicle
lysates. Triton X-100 solubilized rat brain syn-
aptic vesicle preparations were immunopre-
cipitated with TRPM7-C47 or snapin antibody
and immunoprecipitates (IP) were probed on
western blot with TRPM7-CFP (bottom panel)
and snapin (top panel) antibodies. Immuno-
precipitation with TRPM7 antibody pre-absorbed with antigenic peptide (+peptide) and with normal rabbit sera (NS), served as controls for spec-
ificity. X (% of sample used for IP and shown as input) = 2% for TRPM7, and 4% for snapin.
(C) Snapin coimmunoprecipitates TRPM7 from HEK 293T cells expressing two epitope-tagged proteins. FLAG-tagged full-length TRPM7
(Fl-TRPM7) and HA-tagged full-length snapin (HA-snapin) were expressed in HEK 293T cells and cell lysates were immunoprecipitated with
anti-HA antibodies. Precipitates (HA-IP) and cell lysates (10 mg) were probed on western blot with anti-HA (HA-snapin) and anti-FLAG (Fl-TRPM7)
antibodies.The Functional Relevance of TRPM7’s Interaction
with Snapin
Since TRPM7 interacts with synaptic vesicle proteins
involved in the vesicle fusion apparatus, specific disrup-
tion of this interaction might affect evoked neurotrans-
mitter release. Our yeast two-hybrid results suggested
that snapin and TRPM7 could directly interact. However,
the synaptic localization of snapin has been disputed
(Vites et al., 2004). To re-examine this issue, we tested
whether endogenous snapin was in a molecular com-
plex with synaptic vesicle-specific proteins. Snapin,
immunoprecipitated from purified synaptic vesicles,
bound the synaptic vesicle-specific proteins synapsin I
and synaptotagmin I (Figure 5A). Complementary immu-
noprecipitation of synapsin I and synaptotagmin I also
confirmed that snapin is in a molecular complex with
these synaptic vesicle-specific proteins. In these exper-
iments, the synaptic vesicle protein VAMP2 bound Syt1,
but not TRPM7 or snapin, and thus VAMP2 served as a
negative control (Figure 5A). These results confirm that
snapin is indeed associated with synaptic vesicles.
To further examine whether TRPM7 is complexed with
native snapin, we immunoprecipitated TRPM7 from a
solubilized synaptic vesicle preparation. In these exper-
iments, snapin was specifically coimmunoprecipitated
with TRPM7 (Figure 5B). The interaction between TRPM7
and snapin was confirmed in a heterologous expression
system. Full-length FLAG-tagged TRPM7 (coexpressed
with HA-tagged snapin in HEK 293T cells and immuno-
precipitated using FLAG antibody) coimmunoprecipi-
tated snapin (Figure 5C).
To define the region of TRPM7-snapin interaction,
in vitro translated 6xHis-tagged snapin peptide frag-
ments and myc-tagged TRPM7 peptide fragments werelabeled with [35S]-methionine, and histidine-tagged
snapin peptide fragments were pulled down with co-
balt beads. The precipitated fragments were then de-
tected by 35S imaging. These experiments showed that
amino acids 43–68 of snapin were sufficient to bind
the TRPM7 N-terminal fragment (Figure 6A). The re-
gion of TRPM7 critical for snapin binding could not
be further defined beyond that identified in the yeast
two-hybrid assay (amino acids 87–326) because trun-
cations of either the N or C termini of this peptide re-
sulted in the loss of snapin binding (Figure 6B). This
suggests that a 3D fold within amino acids 87–326
of TRPM7 is required for snapin binding.
We next tested whether TRPM7 and snapin directly
bind each other by using purified peptide fragments of
both proteins in an in vitro binding assay. Fusion
proteins of TRPM7 (amino acids 87–326) and maltose
binding protein (MBP-TRPM787–326) and fusion proteins
of snapin (amino acids 43–68) and a 6xHis tag (6xHis-
Snapin43–68) were expressed in bacteria and affinity pu-
rified. Pull down of 6xHis-Snapin43–68 with cobalt beads
demonstrated that Snapin43–68 specifically bound
TRPM787–326 (Figure 6C). In control experiments, MBP
itself did not bind 6xHis-Snapin43–68 and cobalt beads
alone did not bind MBP-TRPM787–326 (Figure 6C).
Thus, if amino acids 43–68 of snapin are also critical
in vivo for TRPM7-snapin complex stabilization, then
a snapin peptide containing these amino acids should
disrupt the TRPM7-snapin native complex. Indeed, a
synthetic peptide comprised of these amino acids spe-
cifically disrupted the native TRPM7-snapin complex as
tested by coimmunoprecipitation of the native mole-
cules (Figure 6D). MBP-TRPM787–326 also specifically
disrupted the native complex in the same assay
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Diagrams depict the protein fragments of TRPM7 and the results of the binding assay. Images are [35S]-autoradiograms of protein gels. Numbers
designate amino acid sequences in full-length proteins. (A) 6xHis-tagged snapin and its fragments were translated in vitro with [35S]-methionine,
combined with in vitro translated [35S]-TRPM7 (87–326), and precipitated with cobalt resin. The image shows that full-length snapin and the sna-
pin peptide fragment (amino acids 43–68) bind the TRPM7 peptide fragment equally well. The nonbinding snapin peptide fragment (83–136) is
shown as a negative control. Snapin structural domains are labeled thus: pTMD, putative transmembrane domain; M7-BD, TRPM7 binding do-
main; CC, coiled coil domain. (B) 6xHis-tagged [35S]-snapin fragment containing amino acids 43–68 and fragments of [35S]-TRPM7 were trans-
lated in vitro and precipitated with cobalt resin. ‘‘Input’’ displays the amount of in vitro translated fragments used in the pull-down assay. (C)
Snapin directly binds TRPM7. Maltose binding protein (MBP) fusion with the TRPM7 peptide fragment (amino acids 87–326; MBP-M7) and
6xHis-snapin peptide fragment (amino acids 43–68; His-Sn) were expressed in bacteria and affinity purified. Point three micrograms of the pro-
teins indicated were combined and 6xHis-snapin was pulled down with cobalt resin. In this Coomassie-stained gel, ‘‘Input’’ displays the amount
of the purified protein used in the pull-down assay. Left lane, molecular markers. His, histidine. (D) The molecules comprising the TRPM7-snapin
binding sites (synthetic snapin43–68 peptide and purified MBP-TRPM787–326 protein) disrupted the native TRPM7-snapin complex. TRPM7 was
immunoprecipitated from a rat brain synaptic vesicle lysate with or without 50 mM snapin43–68 synthetic peptide, scrambled peptide with the iden-
tical amino acid composition, MBP-TRPM787–326, or MBP alone. Immunoprecipitated proteins were probed on western blot with snapin (top
panel) and TRPM7 (lower panel) antibody.(Figure 6D). These interaction-disrupting peptides are
used to probe the functional relevance of the interaction
between TRPM7 and snapin.
Presynaptic neurons were perfused intracellularly
with the TRPM7-snapin disrupting peptide Snapin43-68.
After recording control EPSPs every 20 s for >30 min,
Snapin43–68 peptide was microinjected into presynaptic
neurons. Snapin43–68 injection correlated with a gradual
decrease in the amplitude of evoked EPSPs (Figures 7A
and 7B). Thirty minutes after the start of peptide injec-
tion, the mean EPSP amplitude decreased by 22% 6
7.7% (n = 5). In control injections, the scrambled peptide
at the same concentration caused no significant change
in EPSP amplitudes (+0.6%6 8.4%; p < 0.05; Figure 7C).
Snapin peptide injection also altered the time course of
EPSPs (Figure 7Ab). The first order derivative of EPSP
waveforms shown in Figure 7Ab, representing the rate
of rise and fall for EPSPs, clearly shows that the peptide
reduced the rate of rise of the EPSP and shortened
the time to its peak amplitude. Similar inhibition of
the EPSP amplitude was caused by injection of the
snapin-binding TRPM7 fragment (MBP-TRPM787–326;
Figures 7C and 7D). Injection of heat-denaturedMBP-TRPM787–326 or MBP alone did not alter measured
synaptic transmission. Thus, in vivo disruption of the
TRPM7-snapin complex by two separate, complemen-
tary peptides impaired synaptic transmission in SCG
neurons. That TRPM7 and snapin comprise a synaptic
vesicle molecular complex, and specific in vivo disrup-
tion of this complex inhibits synaptic transmission,
supports the hypothesis that TRPM7 plays a critical
role in neurotransmitter release. The advantage of these
peptide competition experiments, compared to TRPM7
overexpression or siRNA-dependent knockdown, is that
they are acute and thus circumvent artifacts associated
with long-term processes. We conclude that TRPM7 in-
teraction with snapin is important for neurotransmitter
release.
Discussion
We have shown that TRPM7 is localized to the mem-
brane of synaptic vesicles in sympathetic neurons and
forms molecular complexes with the synaptic vesicle
proteins synaptotagmin I, synapsin I, and snapin. In
sympathetic neurons, changes in TRPM7 levels were
Neuron
492Figure 7. Disruption of the TRPM7-Snapin Native Complex Affects EPSP Amplitudes and Kinetics
(A) (Aa) EPSPs from one experiment recorded in a synapse before (23 min) and after (33 min) snapin43–68 injection. (Ab) The first order derivative
of EPSPs shown in (Aa) shows the rate of rise and fall of the EPSP. The vertical marks (red) indicate the time to peak of the EPSP.
(B) Snapin43–68 (0.25 or 2.5 mM in the pipette) or scrambled peptide (2.5 mM in the pipette) was injected into presynaptic neurons at time 0. Pre-
synaptic neurons were stimulated every 20 s. Normalized EPSP amplitudes were averaged (n = 5 each). The resulting values were smoothed with
a moving average algorithm (Experimental Procedures).
(C) MBP-TRPM87–326 (n = 6) or denatured MBP-TRPM87–326 (n = 5) (0.1 mM of each protein in pipette) was injected into presynaptic neurons
at time 0. Insert displays EPSPs from one experiment recorded in a synapse before (25 min) and after (30 min) protein injection.
(D) The mean reduction in EPSP amplitude at 30 min after the start of peptide injection (*p < 0.05 for 2.5 mM snapin43–68 versus scrambled
peptide, MBP-TRPM87–326 versus denatured MBP-TRPM87–326, or MBP alone by the Student’s unpaired t test).correlated with transmitter release as measured by
changes in EPSP amplitudes and kinetics. The domi-
nant-negative TRPM7 pore mutant expressed in SCG
neurons substantially suppressed evoked neurotrans-
mitter release, strongly suggesting that TRPM7’s ionic
conductance is critical for neurotransmitter release. Fur-
thermore, we showed that changes in EPSP amplitudes
depended on TRPM7’s interaction with snapin. The mo-
lecular details of this interaction during vesicle fusion
are unclear; it is possible that snapin is a scaffolding pro-
tein required for assembly of TRPM7 with other synaptic
vesicle proteins, such as synapsin and synaptotagmin.
We hypothesize that TRPM7 functions as an ion con-
ductance pathway across vesicular membranes that is
crucial to transmitter release. Alterations in numbers of
TRPM7 channels or their activity could modulate the
amplitude and kinetics of EPSPs in several ways. Since
TRPM7 was found in the synaptic vesicle membrane,
but not in the plasma membrane, of the synaptic vari-
cosities, the simplest conclusion is that ion flux via
TRPM7 affects either synaptic vesicle-plasma mem-
brane fusion or the amount of neurotransmitter released
from a single vesicle. Calculation of quantal parameters
from EPSPs suggested that TRPM7 alterations affected
quantal size rather than the number of released vesicles
and that TRPM7 vesicular current affects the amount of
neurotransmitter released from a single synaptic vesi-
cle. The amount of the neurotransmitter released from
a single vesicle, or quanta, is not a constant value andis regulated by multiple signaling pathways (Burgoyne
and Barclay, 2002). Consistent with our observation
that TRPM7 affected EPSP kinetics, TRPM7 may affect
quantal release size by altering pore fusion kinetics
(Pawlu et al., 2004). Another possibility is that TRPM7
activity alters transvesicular voltage, which in turn may
affect neurotransmitter release (Thevenod, 2002).
TRPM7 in a Model of Neurotransmitter Release
from Synaptic Vesicles
TRPM7 might regulate the amount of mobile transmitter
contained in a vesicle (Rahamimoff and Fernandez,
1997). This possibility is especially attractive since it pre-
dicts a critical role for the ion channel’s conductance of
ions across the vesicular membrane. Recent findings in-
dicate that transmitters are immobilized in polymeric ion
exchange gels inside vesicles (Nanavati and Fernandez,
1993; Reigada et al., 2003; Uvnas et al., 1989). To release
neurotransmitter from the gel, counterions are required
(Rahamimoff and Fernandez, 1997). The cation channel
in the membrane of the synaptic vesicle would provide
such counterions that could release positively charged
neurotransmitters, such as acetylcholine. TRPM7 is
well-suited for such a function since (1) it is a nonselec-
tive cationic channel; (2) it is outwardly rectifying and its
orientation in the vesicle membrane provides prevailing
cationic flow into the vesicle; and (3) TRPM7 channel
opening requires PIP2 (Runnels et al., 2002), which is
lacking in prefusion synaptic vesicular membranes
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suggests that TRPM7 is inactive before the vesicle asso-
ciates with the plasma membrane. Vesicle attachment/
fusion with the plasma membrane will bring vesicular
TRPM7 into close proximity with PIP2 in the plasma
membrane, resulting in channel opening and cation
flow into the vesicle; (4) TRPM7 activity is strongly acti-
vated at low extracellular pH (Jiang et al., 2005), corre-
sponding to low vesicular intralumenal pH (Fuldner
and Stadler, 1982). Fusion pore formation and communi-
cation with the external solution would dissipate the pH
gradient and inactivate the channel.
The amount of diffusible neurotransmitter affects
quantal size. If the number of vesicular channels pro-
viding counterions for neurotransmitter mobilization is
limiting, then overexpression of the channel should
increase quantal size and would result in an increase
in EPSP amplitude, as observed in our experiments.
Correspondingly, a decrease in the number of channels
should decrease quantal size. Increased mobile neuro-
transmitter in the vesicle would also increase the dura-
tion of neurotransmitter release, resulting in an increase
in EPSP decay time. In this model, channel activation,
ion influx into the vesicle, and neurotransmitter mobili-
zation occur before fusion pore formation. Cation influx
could also rapidly increase vesicular osmotic pressure,
favoring vesicle fusion.
In summary, TRPM7 proteins are in synaptic vesicles
of sympathetic neurons and form a molecular complex
with synaptic vesicle fusion machinery proteins. Ion
conductance via TRPM7 is critical to neurotransmitter
release in these cholinergic synaptic terminals. Colocal-
ization of TRPM7 with synaptophysin in the neuromus-
cular junction implies a role for TRPM7 in neurotransmit-
ter release in the synaptic terminals of motor neurons.
Interestingly, other channels of the TRP superfamily,
TRPV1 and TRPC3, also bind to several components
of the vesicle fusion complex (Morenilla-Palao et al.,
2004; Singh et al., 2004). Mucolipins of the TRPML sub-
family (Di Palma et al., 2002; LaPlante et al., 2002) and
TRPC5 (Bezzerides et al., 2004) have been studied in
intracellular vesicle compartments as regulators of
trafficking, but not as components of the vesicle fusion
apparatus. The findings presented here may signal a role
for other TRP channels in the mechanism of vesicular
fusion.
Experimental Procedures
Yeast Two-Hybrid Screening
Sequences encoding the evolutionarily conserved domains of hu-
man TRPM7 were chosen using GenBank Blast searches. cDNAs
encoding each domain were subcloned into the Gal4 binding do-
main fusion vector pGBKT7 (BD-Clontech). These constructs were
used for screening the human brain library (Matchmaker pACT2,
Clontech) expressed in AH109 yeast.
cDNA Constructs and Recombinant Proteins
We use the abbreviation GFP to refer to Enhanced Green Fluores-
cent Protein. FLAG-tagged mouse TRPM7 in pcDNA4TO was kindly
provided by of Dr. Scharenberg (Univ. Washington). The N-terminal
GFP-TRPM7 fusion protein was made from the above construct by
insertion of GFP into the NotI site between the FLAG and TRPM7 se-
quences. Negative control TRPM7 plasmid was made from the GFP-
TRPM7 construct by creating a stop codon after GFP. The TRPM7
mutation was made using the QuickChange protocol (Stratagene)and the mutated protein was completely sequenced. Human
TRPM787–326 was subcloned into pMAL-c2X (New England Biolabs)
and expressed as an MBP fusion in BL21 CodonPlus bacteria (Stra-
tagene). The MBP fusion protein was affinity purified on amylose
resin (New England Biolabs). For in vitro translation and mammalian
cell expression, coding sequences or fragments of human TRPM7
and snapin were subcloned in frame in a modified pcDNA6 vector
containing the N-terminal fusion protein for an HA- or FLAG-tagged
sequence. His-HA-tagged snapin constructs were made by sub-
cloning the corresponding PCR fragments into a modified 6xHis-
HA vector containing the T7 promoter as described. Fusion peptides
were expressed in BL21 CodonPlus bacteria (Novagen) and purified
on an immobilized cobalt (Talon, Clontech) column. 35S-labeled pro-
teins were made with the T7-TNT system (Invitrogen) and [35S]-me-
thionine, according to the manufacturer’s protocol (Amersham).
Two synthetic double-stranded siRNAs were designed to the unique
regions of rat TRPM7 (bases 975–995 [siRNA1] and 732–772
[siRNA2] of AF375874). Nonsilencing double-stranded RNA (Am-
bion) was used as a negative control.
Antibody, Immunoprecipitation, and Pull-Down Assays
Rabbit TRPM7 antibody (M7-CFP) was made against a glutathione
S-transferase (GST) fusion peptide containing amino acids 1277–
1393 of mouse TRPM7, and affinity purified on an immobilized b-ga-
lactosidase fusion peptide with the same TRPM7 sequence. The
antibody recognized overexpressed TRPM7 on western blot and
immunoprecipitated Flag-TRPM7 expressed in HEK 293T cells. The
antibody was specific for immunofluorescent recognition of FLAG-
TRPM7 expressed in COS-7 cells. A second rabbit TRPM7 antibody
was described earlier (Runnels et al., 2002). Commercially available
antibodies included rabbit snapin antibodies from Synaptic Systems
(Go¨ttingen, Germany); mouse synaptophysin (for western blot),
mouse syntaxin, mouse FLAG (M2) antibodies from Sigma; mouse
synapsin I (for western blot) antibody from BD Transduction; mouse
HA antibody from Santa Cruz Biotechnology; mouse synaptotagmin
I antibody from StressGen (Victoria, Canada); mouse synaptophysin
antibody (for immunofluorescence; US Biological); Na,K-ATPase
and PSD95 from ABR (Golden, Colorado), and rabbit synapsin I an-
tibody (for immunoprecipitation) from Invitrogen (Zymed).
Transfected cells were solubilized in lysis buffer (50 mM Tris-Cl
[pH 8.0], 150 mM NaCl, 1% Triton X-100) supplemented with a prote-
ase inhibitor cocktail (Complete, Roche), immunoprecipitated with
the specified antibody, and washed with lysis buffer. Six- to eight-
week-old rat brain P2 microsomes, synaptosomes, and postsynap-
tic densities were isolated (Carlin et al., 1980) and synaptic vesicles
were purified (Phelan and Gordon-Weeks, 1997). Immunoprecipita-
tion from the synaptic vesicle preparation was performed as de-
scribed above for transfected cells. For TRPM7 antibodies used in
immunoprecipitation experiments, negative controls were verified
by antigen preabsorption. Also, all immunoprecipitating antibodies
were tested for cross-reactivity with in vitro translated coimmuno-
precipitated molecules. Both types of controls confirmed antibody
specificity in immunoprecipitation assays and the absence of
cross-reactivity of immunoprecipitating antibody. For pull-down as-
says, 5 ml of in vitro-translated or 2 mg purified proteins were incu-
bated for 1 hr at 4C with 10 ml cobalt resin in 300 ml RIPA buffer
(20 mM Tris-Cl [pH 8.0], 150 mM NaCl, 1% Triton X-100, 0.5% Na-
Cholate, 0.1% SDS-10 mM imidazole), washed with RIPA buffer,
and solubilized in SDS sample buffer. Proteins were quantified using
a modified Lowry assay (Sigma).
Immunofluorescence and Immunogold Procedures
Low-density rat SCG neurons without glial cells were plated on
cover slips covered with collagen and grown for 40 days as de-
scribed (Mahanthappa and Patterson, 2002). Neurons were fixed
with 4% formaldehyde, permeabilized with 0.2% Triton X-100, and
blocked by 10% goat serum and 1% BSA in PBS. 5 mm sections of
formaldehyde-fixed rat gastrocnemius muscle were prepared as
described (Drake et al., 1997). Sections were additionally fixed in
100% methanol, permeabilized, and blocked as above. Cy3-conju-
gated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories)
and Alexa 488-conjugated goat anti-mouse IgG (Molecular Probes)
were used as secondary antibodies. Images were acquired
with an Olympus Fluoview-500 confocal microscope (603, 1.4 N.A.
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were prepared on plastic coverslips as described below, except
that the preparation was depleted of nonneuronal cells (Lockhart
et al., 2000) and grown for 14 days. Cells were fixed with 4% formal-
dehyde plus 0.01% glutaraldehyde, permeabilized, and blocked
as described above. After incubation with primary antibody,
cells were decorated with goat anti-rabbit Fab fragments labeled
with 1 nm gold particles (Nanogold) with silver enhancement
(Nanoprobes).
Cell Cultures and Gene Expression
HEK 293T cells were grown in DMEM/F12 media supplemented with
glycine, Na-hypoxanthine, penicillin/streptomycin, and 10% FBS.
Cells were transfected using Lipofectamine 2000 (Invitrogen) and
cultured for 48 hr.
Culture of SCG Neurons
Postnatal day 7 Wistar ST rats were decapitated under diethylether
anesthesia according to the guidelines of the Physiological Society
of Japan. Isolated SCG neurons were maintained in culture for 6 to 7
weeks as described (Mochida et al., 1994). In brief, SCGs were dis-
sected, desheathed, and incubated with collagenase (0.5 mg/ml;
Worthington Biochemical) in L-15 (Gibco) at 37C for 10 min. Follow-
ing enzymatic digestion, the semidissociated ganglion was tritu-
rated gently through a small-pore glass pipette until a cloudy sus-
pension was observed. After washing by low-speed centrifugation
at 1300 rpm for 3 min, the collected cells were plated onto coverslips
in plastic dishes (Corning; 35 mm diameter, w1 ganglion per dish)
containing a growth medium of 84% Eagle’s minimal essential me-
dium, 10% fetal calf serum, 5% horse serum, 1% penicillin/strepto-
mycin (Gibco Invitrogen), and 25 ng/ml nerve growth factor (2.5 S,
grade II; Alomone Laboratories). Cells were maintained at 37C in
a 95% air, 5% CO2-humidified incubator, and the medium was
changed twice weekly.
Expression vectors and double stranded RNA (0.2–0.3 mg/ml),
along with the dye Green FCF (3%, Sigma), were microinjected
into SCG neurons through a micropipette (Mochida et al., 2003).
siRNA was microinjected along with the GFP expression vector. En-
try of the constructs into the cell was monitored by the intensity of
the dye. The cells were maintained at 37C in a 95% air, 5% CO2-hu-
midified incubator for 2 or 5 days (siRNA2 and DN), and the injected
neurons were identified by GFP fluorescence with an inverted micro-
scope (Diaphot 300, Nikon) equipped with epifluorescence. The in-
jected neurons were examined as presynaptic neurons in paired
neuronal recordings.
Synaptic Transmission between SCG Neurons
EPSPs were recorded as described (Mochida et al., 1996). Conven-
tional intracellular recordings were made from two neighboring neu-
rons using microelectrodes filled with 1 M KAc (70–90 MU). EPSPs
were recorded from a nontransfected neuron while action potentials
were generated in the GFP-expressing neurons by passage of cur-
rent through an intracellular recording electrode. For Figure 3, five
to ten recordings of EPSPs with ten stimuli at 5 Hz in nine to ten pairs
(910 recordings in total) of each construct-transfected neuron were
performed in a modified Krebs’ solution consisting of 136 mM NaCl,
5.9 mM KCl, 0.2 mM CaCl2, 5 mM MgCl2, 11 mM glucose, and 3 mM
Na-HEPES (pH 7.4). Extracellular Ca2+ and Mg2+ concentrations
were 0.2 mM and 5 mM, respectively, in order to decrease the quan-
tal content of evoked transmitter release (Del Castillo and Katz,
1954). Under these conditions three-fourths of presynaptic action
potentials failed to produce EPSPs, indicating that the majority of
EPSPs represented single, or a few, quantal events. Electrophysio-
logical data were collected using software written by the late Dr. La-
dislav Tauc (CNRS, France; Mochida et al., 1996) and analyzed with
Origin 7.0 (Microcal Software) and the Mini Analysis Program 6.03
(Synaptosoft) for amplitudes and decay times of EPSPs. A Student’s
unpaired t test (two-tailed) was applied to compare EPSPs evoked
by action potentials generated in transfected versus control neu-
rons. The Kolmogorov-Smirnoff test was used to test the
histograms (EPSP amplitude/number) for significance of effects
from transfected synapses compared with control synapses. For
Figure 4B, 6 3 250 action potentials at 5 Hz were applied. The
data were collected by Clampex 9.2 (Axon Instruments) and ana-lyzed with the Mini Analysis Program 6.03 (Synaptosoft). For the
study of the effects of snapin and TRPM7 peptides, neurons were
superfused with a modified Krebs’ solution consisting of 136 mM
NaCl, 5.9 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 11 mM glucose,
and 3 mM Na-HEPES (pH 7.4). Synaptic couples with subthreshold
EPSPs were selected. Peptides were dissolved in 150 mM KAc,
5 mM Mg2+-ATP, and 10 mM HEPES (pH 7.3) and introduced into
the presynaptic cell body by diffusion from a glass suction pipette
(15–20 MU tip resistance). Fast Green FCF (5%, Sigma) was included
via the peptide injection solution to confirm entry into the presynap-
tic cell body. The injection pipette was removed 3 to 4 min after the
start of the injection. The peak amplitudes of EPSPs were averaged
and the resultant values were smoothed by an eight-point moving
average algorithm and plotted against recording time with t = 0 indi-
cating the start of presynaptic injection of peptides. The Student’s
unpaired t test (two-tailed) was applied to compare effects among
presynaptic neurons injected with peptides. I-V curves were plotted
using Clampex 9.2 (Axon Instruments).
Membrane input resistance was determined from the linear por-
tion of three I-V curves and membrane input capacitance was calcu-
lated from the averaged membrane time constant and input resis-
tance using Clampfit 9.2 (Axon Instruments). ACh responses were
elicited by puff application of 5 mM ACh (3 psi, 20 ms) to a postsynap-
tic neuron every 5 s for 5 min. Data values with associated error,
shown in the text and figures, represent mean 6 SEM.
Quantal Analysis
Quantal analysis for postsynaptic potentials induced by action po-
tentials generated in presynaptic neurons transfected with the
TRPM7 constructs was performed using the variance method (Del
Castillo and Katz, 1954). In this method, the quantal size (q, unitary
response to a single quantum) and the quantal content (m, number
of quanta released) are calculated by analyzing the distribution of
a population of evoked EPSPs under the assumption that release
of synaptic vesicle quanta follows a Poisson distribution. The
mean (E) and standard deviation (s) of this series of experiments
were determined by the Mini Analysis Program 6.03 (Synaptosoft).
The quantal content (m) was calculated from m = 1/(cv)2, where
cv = s/E. The quantal size (q) was calculated from q = E/m.
TRPM7 Expression and Current Measurements in CHO-K Cells
CHO-K1 cells were transfected with 0.5–3 mg of cDNA as described
above for HEK 293T cells. Whole-cell patch-clamp recording was
performed 1 or 2 days posttransfection while cells were bathed in
an extracellular solution containing, in mM, 130 NaCl, 5 CsCl, 1
CaCl2, 10 Na-HEPES, and 10 glucose (pH 7.4). Patch pipettes pulled
from borosilicate glass had resistances ofw2–4 MUwhen filled with
the intracellular recording solution, consisting of, in mM, 125 Cs-
methanesulfonate, 8 NaCl, 10 EGTA, 4.1 CaCl2, and 10 HEPES (pH
7.4). Currents were recorded using an Axopatch 200A amplifier
(Axon Instruments), filtered on-line at 2 kHz, sampled at an interval
of 100 ms, and digitized using a Digidata 1322A and pClamp 9.2 soft-
ware (Axon Instruments). Series resistance was <12.0 MU, and this
was compensated byw85% during experiments.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/3/485/DC1/.
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